News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
626,832 Results
Type
Article (45479)
Company Profile (328)
Press Release (581025)
Section
Business (177353)
Career Advice (2573)
Deals (32177)
Drug Delivery (111)
Drug Development (80193)
Employer Resources (153)
FDA (15144)
Job Trends (13511)
News (311047)
Policy (30394)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (14)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (7)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
Academia (2736)
Academic (1)
Accelerated approval (3)
Adcomms (26)
Allergies (80)
Alliances (44621)
ALS (91)
Alzheimer's disease (1428)
Antibody-drug conjugate (ADC) (128)
Approvals (15128)
Artificial intelligence (242)
Autoimmune disease (18)
Automation (14)
Bankruptcy (335)
Best Places to Work (11023)
BIOSECURE Act (16)
Biosimilars (96)
Biotechnology (261)
Bladder cancer (65)
Brain cancer (27)
Breast cancer (257)
Cancer (2057)
Cardiovascular disease (178)
Career advice (2163)
Career pathing (31)
CAR-T (150)
Cell therapy (424)
Cervical cancer (17)
Clinical research (64741)
Collaboration (779)
Compensation (339)
Complete response letters (29)
COVID-19 (2633)
CRISPR (42)
C-suite (226)
Cystic fibrosis (102)
Data (1965)
Decentralized trials (2)
Denatured (17)
Depression (48)
Diabetes (258)
Diagnostics (6018)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (40)
Drug discovery (115)
Drug pricing (109)
Drug shortages (31)
Duchenne muscular dystrophy (91)
Earnings (67100)
Editorial (38)
Employer branding (21)
Employer resources (138)
Events (93884)
Executive appointments (661)
FDA (16243)
Featured Employer (44)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (698)
Gene editing (104)
Generative AI (21)
Gene therapy (309)
GLP-1 (749)
Government (4469)
Grass and pollen (4)
Guidances (47)
Healthcare (17948)
Huntington's disease (24)
IgA nephropathy (26)
Immunology and inflammation (121)
Indications (27)
Infectious disease (2771)
Inflammatory bowel disease (144)
Inflation Reduction Act (11)
Influenza (48)
Intellectual property (88)
Interviews (535)
IPO (14960)
IRA (47)
Job creations (2931)
Job search strategy (1780)
Kidney cancer (10)
Labor market (21)
Layoffs (458)
Leadership (19)
Legal (6725)
Liver cancer (74)
Lung cancer (304)
Lymphoma (131)
Machine learning (4)
Management (53)
Manufacturing (262)
MASH (67)
Medical device (11855)
Medtech (11859)
Mergers & acquisitions (17682)
Metabolic disorders (679)
Multiple sclerosis (74)
NASH (23)
Neurodegenerative disease (92)
Neuropsychiatric disorders (31)
Neuroscience (1945)
NextGen: Class of 2025 (6227)
Non-profit (4253)
Northern California (2261)
Now hiring (35)
Obesity (366)
Opinion (249)
Ovarian cancer (73)
Pain (83)
Pancreatic cancer (77)
Parkinson's disease (139)
Partnered (19)
Patents (209)
Patient recruitment (93)
Peanut (49)
People (55713)
Pharmaceutical (61)
Pharmacy benefit managers (17)
Phase I (20259)
Phase II (28557)
Phase III (21327)
Pipeline (1047)
Podcasts (72)
Policy (121)
Postmarket research (2483)
Preclinical (8578)
Press Release (64)
Prostate cancer (95)
Psychedelics (37)
Radiopharmaceuticals (257)
Rare diseases (387)
Real estate (4775)
Recruiting (63)
Regulatory (21216)
Reports (27)
Research institute (2350)
Resumes & cover letters (380)
Rett syndrome (3)
RNA editing (4)
RSV (39)
Schizophrenia (73)
Series A (125)
Series B (81)
Service/supplier (4)
Sickle cell disease (56)
Southern California (2034)
Special edition (15)
Spinal muscular atrophy (154)
Sponsored (29)
Startups (3295)
State (2)
Stomach cancer (15)
Supply chain (58)
The Weekly (53)
United States (20159)
Vaccines (668)
Venture capitalists (37)
Webinars (13)
Weight loss (260)
Women's health (27)
Worklife (17)
Date
Today (224)
Last 7 days (700)
Last 30 days (2717)
Last 365 days (33050)
2025 (7847)
2024 (34510)
2023 (38549)
2022 (49557)
2021 (53522)
2020 (51787)
2019 (44221)
2018 (33369)
2017 (31015)
2016 (29715)
2015 (34763)
2014 (27001)
2013 (22092)
2012 (23421)
2011 (24303)
2010 (21997)
Location
Africa (791)
Alabama (51)
Alaska (4)
Arizona (176)
Arkansas (12)
Asia (39015)
Australia (7447)
California (5245)
Canada (1810)
China (476)
Colorado (239)
Connecticut (236)
Delaware (127)
Europe (85491)
Florida (778)
Georgia (183)
Idaho (56)
Illinois (470)
India (25)
Indiana (279)
Iowa (6)
Japan (143)
Kansas (93)
Kentucky (21)
Louisiana (8)
Maine (52)
Maryland (824)
Massachusetts (4008)
Michigan (199)
Minnesota (335)
Mississippi (2)
Missouri (72)
Montana (29)
Nebraska (22)
Nevada (52)
New Hampshire (66)
New Jersey (1527)
New Mexico (27)
New York (1507)
North Carolina (909)
North Dakota (6)
Northern California (2261)
Ohio (176)
Oklahoma (11)
Oregon (33)
Pennsylvania (1154)
Puerto Rico (9)
Rhode Island (25)
South America (1095)
South Carolina (17)
South Dakota (1)
Southern California (2034)
Tennessee (84)
Texas (781)
Utah (164)
Virginia (129)
Washington D.C. (52)
Washington State (489)
West Virginia (3)
Wisconsin (44)
626,832 Results for "prescient therapeutics formerly known as virax holdings limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait
January 24, 2025
·
4 min read
Business
Prescient Healthcare Group Appoints Two New Members to its Board of Directors
Prescient Healthcare Group , a leading biopharma product and portfolio strategy firm, has announced the appointment of two new members to its Board of Directors – Dr. Luke Solon and Debbie Allman – to help shape and drive Prescient’s global mission.
April 19, 2024
·
3 min read
Press Releases
Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries
January 13, 2025
·
6 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Celltrion’s Remdantry™, previously known as Inflectra®, will be available in Canada as of April 1, 2025
March 27, 2025
·
3 min read
Business
Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits
Virax Biolabs Group Limited announced today that it has entered into an agreement for the distribution of Marburg Virus PCR testing kits.
April 19, 2023
·
4 min read
Press Releases
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering
January 8, 2025
·
4 min read
Press Releases
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option
January 14, 2025
·
4 min read
Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study
Virax Biolabs Group Limited announced today the initiation of its Virax Immune COVID-19 Analytical Performance Study scheduled to take place through Q4 of this year.
October 26, 2022
·
4 min read
1 of 62,684
Next
